LBI-HTA – Ludwig Boltzmann Institute for Health Technology Assessment

austria_flag  Vienna, Austria

LBI-HTA_C.Wild_sm

"HTA is as much a culture of thinking as it is a method. Austrian decision makers have to be gradually convinced of HTA's potential."
 – Dr. Claudia Wild, Director, LBI-HTA

 

History and Structure

The Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) was founded in April 2006 for the duration of seven years. In 2013 the LBI-HTA was prolongated for another 7 years until 2020.The budget of the LBI-HTA averages € 1.1 million p.a. and is funded by the institutional partners (60%) and the Ludwig Boltzmann Society (40 %).

In line with the research policy of the Ludwig Boltzmann Society, the LBI-HTA focuses on translational research. According to the research programme, strong emphasis is put on applicable short term or medium term results. By setting up partnerships between research-producing and research-applying organizations or institutions, for the constitution and financing of the institute the quick transfer of research results is guaranteed.

The partners define the annual research program in a process of more or less systematic priority setting and committed themselves by becoming "partners" to put the results into practice. The institutional partners benefit from synthesized understanding by gaining research-based arguments that provide them with a rationale independent of interest groups. Because of the direct communication with the decision-maker the results show traceable impact. All projects engage an interdisciplinary team, they are presented and critically reviewed at internal seminars and undergo an external review process.

Partners of the Ludwig Boltzmann Institute for Health Technology Assessment are actors in health care administration (Ministry of Health, Austrian Federation of Social and Health Insurances, regional health funds).

Mission

The LBI-HTA regards itself as an independent entity for scientific decision-making support in the health sector.

  • We provide the scientific basis for decisions in favor of an efficient and appropriate use of resources.
  • Medical interventions are analyzed under a broad socially-relevant perspective and in the context of a qualitative concept of progress.
  • We see ourselves as an innovative and creative interdisciplinary think tank that has also included the further development of HTA methodology within its objectives.
  • Special importance is attached to the traceability of our results: systematic analysis and the disclosure of our methods make our results open to scrutiny.
  • We work at a distance to interest groups and refuse to fall within their influence, be they fund providers or market suppliers.
  • Intensive international networking allows us to avoid redundancies and to remain at the leading edge of knowledge.

Our mission statement can be summarized as follows:

  • Independence and distance to interest groups
  • Qualitative concept of progress
  • Multidisciplinary perspective
  • Accountable results due to stringent methods
  • International cooperation

Dissemination Activities

Research finding are disseminated in the form of reports downloadable free-of-charge from the LBI-HTA website and repository, articles in reviewed and non-reviewed journals as well as key messages to specific (medical) interest groups. Raising public awareness of HTA as a policy instrument is of paramount importance for the LBI-HTA. A monthly newsletter (2000 recipients) is published, public seminars (attended regularly by 20-30 "mediators") are organized, presentations at the main national health care congresses and lectures at professional trainings are held in order to achieve the above aim.

Published, planned & ongoing projects:
http://hta.lbg.ac.at/page/alle-projekte-im-ueberblick

Repository (free access & download):
http://eprints.hta.lbg.ac.at/

Future Thematic Focus (9 fields of research)

  • Oncology
  • High-tech medicine
  • Rehabilitation and occupational therapy
  • Prevention and screening
  • Psychological and psychiatric interventions
  • Health economics
  • European collaboration
  • HTA-methods and steering instruments
  • Complementary medicine

     


Agency Information

LBI

Country: Austria
Description of population served: National
Population served (mil): 8.0
Current HTA budget (mil USD): 1.5
Permanent staff: 16=13 FTE
Consultants: variable
Ongoing TA projects: 9-12


Contact Information

Director: Dr. Claudia Wild
Contact person: Ms. Judit Erdos

Ludwig Boltzmann Institute for Health Technology Assessment
Garnisongasse 7/rechte Steige Mezzanin (top 20)
A-1090 Vienna Austria

Tel: +43 1 23681191-0
Fax: +43 1 236811999
Internet: http://hta.lbg.ac.at
Email: claudia.wild@hta.lbg.ac.at; judit.erdos@hta.lbg.ac.at